These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 2673025)
21. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review. Olejniczak K; Kasprzak A Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208 [TBL] [Abstract][Full Text] [Related]
25. beta-Glycosphingolipids as immune modulators. Adar T; Ilan Y J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392 [TBL] [Abstract][Full Text] [Related]
26. Defective T cell response to presented antigen in autoimmune mice. Fischbach M J Immunol; 1984 Nov; 133(5):2365-8. PubMed ID: 6332846 [TBL] [Abstract][Full Text] [Related]
27. Role of suppressor T cells in lymphopoietic disorders. Steinberg AD; Klassen LW Clin Haematol; 1977 Jun; 6(2):439-78. PubMed ID: 71963 [No Abstract] [Full Text] [Related]
28. [The expression of IL-2 receptor alpha subunit in T cells]. Liu CB; Arai K Nihon Rinsho; 1997 Mar; 55 Suppl 1():183-8. PubMed ID: 9097585 [No Abstract] [Full Text] [Related]
29. Receptor-mediated endocytosis of IL-2 by PHA stimulated lymphocytes. Lee TP; Mookerjee BK Transplant Proc; 1989 Feb; 21(1 Pt 1):100-2. PubMed ID: 2784877 [No Abstract] [Full Text] [Related]
30. The suppressor-cell network in cancer (second of two parts). Broder S; Waldmann TA N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202 [No Abstract] [Full Text] [Related]
31. Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor. Vie H; Gauthier T; Breathnach R; Bonneville M; Godard A; Dietrich J; Karam G; Gesnel MC; Peyrat MA; Jacques Y Transplant Proc; 1993 Feb; 25(1 Pt 1):741-2. PubMed ID: 8438463 [No Abstract] [Full Text] [Related]
32. Regulatory T cells: magic bullets for immunotherapy? Frey O; Bräuer R Arch Immunol Ther Exp (Warsz); 2006; 54(1):33-43. PubMed ID: 16642255 [TBL] [Abstract][Full Text] [Related]
33. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections. Diamantstein T Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248 [No Abstract] [Full Text] [Related]
34. Immune deficiency of the uremic patient. Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582 [No Abstract] [Full Text] [Related]
39. The 1977 Bela Schick Memorial Lecture: disorders of suppressor cells in the pathogenesis of immunodeficiency, autoimmune and allergic diseases: human disease associated with disorders of an immunological breaking system. Waldmann TA Ann Allergy; 1977 Aug; 39(2):79-86. PubMed ID: 329718 [TBL] [Abstract][Full Text] [Related]